These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 19602345)

  • 1. [The profiling era: towards innovative approaches for tailored therapy].
    Roulland S; Nadel B
    Med Sci (Paris); 2009; 25(6-7):553-5. PubMed ID: 19602345
    [No Abstract]   [Full Text] [Related]  

  • 2. New concepts in treatment approaches and prognostic factors in aggressive NHL.
    Shipp M
    Clin Adv Hematol Oncol; 2006 Feb; 4(2):107-9. PubMed ID: 16728917
    [No Abstract]   [Full Text] [Related]  

  • 3. Diffuse large B-cell lymphoma.
    Habermann TM
    Clin Adv Hematol Oncol; 2005 Nov; 3(11):suppl 4-5. PubMed ID: 16491628
    [No Abstract]   [Full Text] [Related]  

  • 4. Prediction of survival in diffuse large-B-cell lymphoma based on the expression of six genes.
    Lossos IS; Czerwinski DK; Alizadeh AA; Wechser MA; Tibshirani R; Botstein D; Levy R
    N Engl J Med; 2004 Apr; 350(18):1828-37. PubMed ID: 15115829
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Translating cancer genomics into clinical oncology.
    Ramaswamy S
    N Engl J Med; 2004 Apr; 350(18):1814-6. PubMed ID: 15115827
    [No Abstract]   [Full Text] [Related]  

  • 6. [Gene expression profiling of de novo CD5-positive diffuse large B-cell lymphoma].
    Kobayashi T; Kim S; Zhang W; Yamaguchi M; Ueno S; Morikawa J; Shiku H
    Rinsho Ketsueki; 2003 Mar; 44(3):144-8. PubMed ID: 12722340
    [No Abstract]   [Full Text] [Related]  

  • 7. Molecular characteristics of diffuse large-B-cell lymphoma.
    Magrath I
    N Engl J Med; 2002 Jun; 346(25):1998-9. PubMed ID: 12075062
    [No Abstract]   [Full Text] [Related]  

  • 8. [Clinical application of gene-expression profiling in lymphome].
    Jardin F; Tilly H
    Med Sci (Paris); 2004 Oct; 20(10):848-50. PubMed ID: 15461956
    [No Abstract]   [Full Text] [Related]  

  • 9. Prediction of clinical behaviour and treatment for cancers.
    Futschik ME; Sullivan M; Reeve A; Kasabov N
    Appl Bioinformatics; 2003; 2(3 Suppl):S53-8. PubMed ID: 15130817
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Burkitt's lymphoma--the message from microarrays.
    Harris NL; Horning SJ
    N Engl J Med; 2006 Jun; 354(23):2495-8. PubMed ID: 16760450
    [No Abstract]   [Full Text] [Related]  

  • 11. Advances in the treatment of hematologic malignancies. Part 1 of a 3-part series: Aggressive lymphomas.
    Fisher RI; Coiffier B; Vose JM
    Clin Adv Hematol Oncol; 2006 Apr; 4(4):suppl 1, 4-9; discussion suppl 10; quiz 2 p following suppl 10. PubMed ID: 16775878
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diffuse large B-cell lymphoma outcome prediction by gene-expression profiling and supervised machine learning.
    Shipp MA; Ross KN; Tamayo P; Weng AP; Kutok JL; Aguiar RC; Gaasenbeek M; Angelo M; Reich M; Pinkus GS; Ray TS; Koval MA; Last KW; Norton A; Lister TA; Mesirov J; Neuberg DS; Lander ES; Aster JC; Golub TR
    Nat Med; 2002 Jan; 8(1):68-74. PubMed ID: 11786909
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular profiling of lymphoma.
    Akhtar S
    N Engl J Med; 2002 Oct; 347(17):1376-7; author reply 1376-7. PubMed ID: 12397201
    [No Abstract]   [Full Text] [Related]  

  • 14. Introduction of combined CHOP plus rituximab therapy dramatically improved outcome of diffuse large B-cell lymphoma in British Columbia.
    Sehn LH; Donaldson J; Chhanabhai M; Fitzgerald C; Gill K; Klasa R; MacPherson N; O'Reilly S; Spinelli JJ; Sutherland J; Wilson KS; Gascoyne RD; Connors JM
    J Clin Oncol; 2005 Aug; 23(22):5027-33. PubMed ID: 15955905
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Management of cutaneous B-cell lymphoma: recommendations of the French cutaneous lymphoma study group].
    Grange F; D'Incan M; Ortonne N; Dalac S; Laroche L; Beylot-Barry M; Delfau-Larue MH; Vergier B; Bagot M;
    Ann Dermatol Venereol; 2010; 137(8-9):523-31. PubMed ID: 20804896
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Prognostic value of gene expression profiling using cDNA arrays in lymphomas].
    Bertucci F; Salas S; Nasser V; Houlgatte R; Birnbaum D; Xerri L
    Bull Cancer; 2002; 89(7-8):661-5. PubMed ID: 12206978
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The microarray way to tailored cancer treatment.
    Van 't Veer LJ; De Jong D
    Nat Med; 2002 Jan; 8(1):13-4. PubMed ID: 11786894
    [No Abstract]   [Full Text] [Related]  

  • 18. Prognostic signature of ALL blasts at diagnosis: what can we really find?
    Gandemer V; de Tayrac M; Mosser J; Galibert MD
    Leuk Res; 2007 Sep; 31(9):1317-9. PubMed ID: 17113638
    [No Abstract]   [Full Text] [Related]  

  • 19. The feasibility of gene expression profiling generated in fine-needle aspiration specimens from patients with follicular lymphoma and diffuse large B-cell lymphoma.
    Goy A; Stewart J; Barkoh BA; Remache YK; Katz R; Sneige N; Gilles F
    Cancer; 2006 Feb; 108(1):10-20. PubMed ID: 16329118
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Developing new monoclonal antibodies for aggressive lymphoma: a challenging road in the rituximab era.
    Friedberg JW
    Clin Cancer Res; 2004 Aug; 10(16):5297-8. PubMed ID: 15328164
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.